CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
No intervention was applied to the groups the samples will be collected in terms of the diagnosis (periodontitis, healthy)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05306860
NCT05306860N/ACompleted

Investigation of the Relationships and Clinical Parameters Between IL-6, IL-17 and IL-35 Levels in the Gingival Crevicular Fluid of Individuals With Grade B-C Stage III-IV Periodontitis

Istanbul University·observational·Posted Apr 1, 2022·Updated Mar 5, 2024

In Brief

An observational study evaluating No intervention was applied to the groups the samples will be collected in terms of the diagnosis (periodontitis, healthy) for Periodontitis. Completed, enrolled 60 participants across 1 site.

Detailed Summary

Periodontitis is an inflammatory disease characterized by periodontal tissue destruction caused by bacterial infection. The immune response plays an important role in the progression of periodontitis. The disease process starts with periodontopathogens in dental plaque, and tissue destruction is mainly caused by the immune response of the host to the etiological microorganism and cytokine profile through various inflammatory cytokines. The cytokine response, which plays a critical role in the pathogenesis of periodontal disease, determines the progression of the disease. Evaluation of the effects of IL-6, IL-17 and IL-35 levels in the gingival crevicular fluid on periodontal disease together with clinical parameters has been the basis of our study. This study consists of individuals with grad B-C stage III-IV periodontitis and healthy individuals, which is the subtitle of Periodontal and Periimplant Diseases and Conditions in the classification renewed in 2017. It is aimed to examine the changes and possible correlations in IL-6, IL-17, IL-35 levels as a result of biochemical examination of the samples taken from the gingival crevicular fluid. In our study, according to the new classification of 2017, gingival crevicular fluid samples collected from individuals with grade B-C stage III-IV periodontal disease and healthy individuals under appropriate conditions and techniques were measured for IL-6, IL-17 and IL-35 by enzymatic immunosorbent test (ELISA). It aims to investigate the negative/positive correlations and compare the increases-decreases.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeriodontitis
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedApr 1, 2022
Enrollment StartApr 15, 2022
Primary CompletionNov 30, 2022
Study CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.3 years ago

Interventions

No intervention was applied to the groups the samples will be collected in terms of the diagnosis (periodontitis, healthy)other

No intervention was applied to the groups the samples will be collected in terms of the diagnosis (periodontitis, healthy)